No Data
Here's Why Moderna, Inc. (MRNA) Is Among Monday's Top Losers
Express News | Moderna : Leerink Partners Cuts Target Price to $27 From $31
The pandemic benefits have completely faded! Moderna (MRNA.US) has lowered its sales forecast for 2025 by 1 billion dollars.
Moderna (MRNA.US) has lowered its sales expectations for 2025 by about 1 billion dollars due to some unfavorable factors that may arise later this year.
S&P 500 Gains and Losses Today: Moderna Plunges After Big Cut to Sales Forecast
BofA Securities Maintains Moderna(MRNA.US) With Sell Rating, Maintains Target Price $41
Moderna Options Spot-On: On January 13th, 239.46K Contracts Were Traded, With 756.28K Open Interest
On January 13th ET, $Moderna(MRNA.US)$ had active options trading, with a total trading volume of 239.46K options for the day, of which put options accounted for 44.47% of the total transactions,